{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:44:20Z","timestamp":1785516260863,"version":"3.56.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T00:00:00Z","timestamp":1497484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T00:00:00Z","timestamp":1497484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The side effects of cisplatin (CDDP), notably nephrotoxicity, greatly limited its use in clinical chemotherapy. HuangQi Injections (HI), a commonly used preparation of the well-known Chinese herbal medicine <jats:italic>Astragali radix<\/jats:italic>, appeared to be promising treatment for nephrotoxicity without compromising the anti-tumor activity of CDDP. In this study, the urinary metabolomics approach using liquid chromatography time of flight mass spectrometry (LC-TOF\/MS) was developed to assess the toxicity-attenuation effects and corresponding mechanisms of HI on CDDP-exposed rats. As a result, successive administration of HI significantly recovered the decline of body weight and downregulated the abnormal increase of serum creatinine and urea. HI partly restored the CDDP-induced alteration of metabolic profiling back into normal condition. Totally 43 toxicity-attenuation potential biomarkers were screened and tentatively identified, which were involved in important metabolic pathways such as amino acid metabolism, TCA cycle, fatty acid metabolism, vitamin B6 metabolism and purine metabolism. The results clearly revealed that HI could alleviate CDDP-induced nephrotoxicity and improve the disturbed metabolic balance induced by repeated CDDP exposure. The present study provided reliable evidence for the protective effect of HI on CDDP-induced toxicity with the multi-target pharmacological characteristics.<\/jats:p>","DOI":"10.1038\/s41598-017-03249-z","type":"journal-article","created":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T14:20:33Z","timestamp":1497018033000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Urinary metabolomics reveals the therapeutic effect of HuangQi Injections in cisplatin-induced nephrotoxic rats"],"prefix":"10.1038","volume":"7","author":[{"given":"Chang-Yin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ting","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Yao","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan-Sheng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Liang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Heng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Zheng","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,15]]},"reference":[{"key":"3249_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/B978-0-12-800141-7.00003-6","volume":"65","author":"YY Zhao","year":"2014","unstructured":"Zhao, Y. Y. & Lint, R. C. Metabolomics in nephrotoxicity. Advances in clinical chemistry. \n                           65, 69\u201389 (2014).","journal-title":"Advances in clinical chemistry."},{"key":"3249_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cca.2013.03.033","volume":"422","author":"YY Zhao","year":"2013","unstructured":"Zhao, Y. Y. Metabolomics in chronic kidney disease. Clinica chimica acta; international journal of clinical chemistry. \n                           422, 59\u201369 (2013).","journal-title":"Clinica chimica acta; international journal of clinical chemistry."},{"key":"3249_CR3","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cbi.2016.03.028","volume":"252","author":"DQ Chen","year":"2016","unstructured":"Chen, D. Q. et al. Metabolomic application in toxicity evaluation and toxicological biomarker identification of natural product. Chemico-biological interactions. \n                           252, 114\u2013130 (2016).","journal-title":"Chemico-biological interactions."},{"key":"3249_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.kint.2016.08.021","volume":"91","author":"S Kalim","year":"2017","unstructured":"Kalim, S. & Rhee, E. P. An overview of renal metabolomics. Kidney international. \n                           91, 61\u201369 (2017).","journal-title":"Kidney international."},{"key":"3249_CR5","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1038\/sj.ki.5000433","volume":"69","author":"D Portilla","year":"2006","unstructured":"Portilla, D. et al. Metabolomic study of cisplatin-induced nephrotoxicity. Kidney Int. \n                           69, 2194\u2013204 (2006).","journal-title":"Kidney Int."},{"key":"3249_CR6","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1021\/acs.chemrestox.5b00519","volume":"29","author":"P Zhang","year":"2016","unstructured":"Zhang, P. et al. Discovery of potential biomarkers with dose- and time-dependence in cisplatin-induced nephrotoxicity using metabolomics integrated with a principal component-based area calculation strategy. Chemical research in toxicology. \n                           29, 776\u2013783 (2016).","journal-title":"Chemical research in toxicology."},{"key":"3249_CR7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4155\/bio.14.309","volume":"7","author":"YY Zhao","year":"2015","unstructured":"Zhao, Y. Y. et al. Urinary metabolomics and biomarkers of aristolochic acid nephrotoxicity by UPLC-QTOF\/HDMS. Bioanalysis. \n                           7, 685\u2013700 (2015).","journal-title":"Bioanalysis."},{"key":"3249_CR8","doi-asserted-by":"publisher","first-page":"12936","DOI":"10.1038\/srep12936","volume":"5","author":"YY Zhao","year":"2015","unstructured":"Zhao, Y. Y. et al. Metabolomics analysis reveals the association between lipid abnormalities and oxidative stress, inflammation, fibrosis, and Nrf2 dysfunction in aristolochic acid-induced nephropathy. Scientific reports. \n                           5, 12936 (2015).","journal-title":"Scientific reports."},{"key":"3249_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.redox.2016.09.014","volume":"10","author":"H Chen","year":"2016","unstructured":"Chen, H. et al. Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression. Redox Biol. \n                           10, 168\u2013178 (2016).","journal-title":"Redox Biol."},{"key":"3249_CR10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ki.2008.129","volume":"74","author":"FD Debelle","year":"2008","unstructured":"Debelle, F. D., Vanherweghem, J. L. & Nortier, J. L. Aristolochic acid nephropathy: a worldwide problem. Kidney Int. \n                           74, 158\u2013169 (2008).","journal-title":"Kidney Int."},{"key":"3249_CR11","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/ki.2013.276","volume":"84","author":"Y Zhong","year":"2013","unstructured":"Zhong, Y. et al. Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases. Kidney Int. \n                           84, 1108\u20131118 (2013).","journal-title":"Kidney Int."},{"key":"3249_CR12","doi-asserted-by":"publisher","first-page":"14472","DOI":"10.1038\/srep14472","volume":"5","author":"ZH Zhang","year":"2015","unstructured":"Zhang, Z. H. et al. Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis. Scientific reports. \n                           5, 14472 (2015).","journal-title":"Scientific reports."},{"key":"3249_CR13","doi-asserted-by":"publisher","first-page":"22151","DOI":"10.1038\/srep22151","volume":"6","author":"ZH Zhang","year":"2016","unstructured":"Zhang, Z. H. et al. An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure. Scientific reports. \n                           6, 22151 (2016).","journal-title":"Scientific reports."},{"key":"3249_CR14","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1039\/C4MB00573B","volume":"11","author":"Z Xiang","year":"2015","unstructured":"Xiang, Z. et al. The study on the material basis and the mechanism for anti-renal interstitial fibrosis efficacy of rhubarb through integration of metabonomics and network pharmacology. Mol Biosyst. \n                           11, 1067\u20131078 (2015).","journal-title":"Mol Biosyst."},{"key":"3249_CR15","doi-asserted-by":"publisher","first-page":"e59617","DOI":"10.1371\/journal.pone.0059617","volume":"8","author":"YY Zhao","year":"2013","unstructured":"Zhao, Y. Y. et al. Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism. PLoS One \n                           8, e59617 (2013).","journal-title":"PLoS One"},{"key":"3249_CR16","first-page":"202","volume":"81\u201382","author":"YY Zhao","year":"2013","unstructured":"Zhao, Y. Y. et al. Renal metabolic profiling of early renal injury and renoprotective effects of Poria cocos epidermis using UPLC Q-TOF\/HSMS\/MSE. J Pharm Biomed Anal. \n                           81\u201382, 202\u20139 (2013).","journal-title":"J Pharm Biomed Anal."},{"key":"3249_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jep.2013.04.018","volume":"148","author":"YY Zhao","year":"2013","unstructured":"Zhao, Y. Y. et al. Urinary metabonomic study of the surface layer of Poria cocos as an effective treatment for chronic renal injury in rats. J Ethnopharmacol. \n                           148, 403\u2013410 (2013).","journal-title":"J Ethnopharmacol."},{"key":"3249_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jep.2010.11.064","volume":"134","author":"H You","year":"2011","unstructured":"You, H. et al. Aqueous extract of Astragali Radix ameliorates proteinuria in adriamycin nephropathy rats through inhibition of oxidative stress and endothelial nitric oxide synthase. Journal of ethnopharmacology. \n                           134, 176\u2013182 (2011).","journal-title":"Journal of ethnopharmacology."},{"key":"3249_CR19","doi-asserted-by":"crossref","unstructured":"Zhang, H. W., Lin, Z. X., Xu, C., Leung, C. & Chan, L. S. Astragalus (a traditional Chinese medicine) for treating chronic kidney disease. The Cochrane database of systematic reviews CD008369 (2014).","DOI":"10.1002\/14651858.CD008369.pub2"},{"key":"3249_CR20","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3748\/wjg.v9.i4.670","volume":"9","author":"J Lin","year":"2003","unstructured":"Lin, J., Dong, H. F., Oppenheim, J. J. & Howard, O. M. Effects of astragali radix on the growth of different cancer cell lines. World journal of gastroenterology. \n                           9, 670\u2013673 (2003).","journal-title":"World journal of gastroenterology."},{"key":"3249_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cbi.2014.02.014","volume":"215","author":"YY Zhao","year":"2014","unstructured":"Zhao, Y. Y. & Lin, R. C. UPLC-MS(E) application in disease biomarker discovery: the discoveries in proteomics to metabolomics. Chemico-biological interactions \n                           215, 7\u201316 (2014).","journal-title":"Chemico-biological interactions"},{"key":"3249_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.clinbiochem.2014.07.019","volume":"47","author":"YY Zhao","year":"2014","unstructured":"Zhao, Y. Y., Cheng, X. L., Vaziri, N. D., Liu, S. & Lin, R. C. UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry. Clinical biochemistry. \n                           47, 16\u201326 (2014).","journal-title":"Clinical biochemistry."},{"key":"3249_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/jssc.201500634","volume":"39","author":"Z Li","year":"2016","unstructured":"Li, Z., Chen, K., Guo, M. Z. & Tang, D. Q. Two-dimensional liquid chromatography and its application in traditional Chinese medicine analysis and metabonomic investigation. Journal of separation science. \n                           39, 21\u201337 (2016).","journal-title":"Journal of separation science."},{"key":"3249_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jpba.2013.06.032","volume":"87","author":"HG Gika","year":"2014","unstructured":"Gika, H. G., Theodoridis, G. A., Plumb, R. S. & Wilson, I. D. Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics. J Pharm Biomed Anal. \n                           87, 12\u201325 (2014).","journal-title":"J Pharm Biomed Anal."},{"key":"3249_CR25","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1021\/pr3007792","volume":"12","author":"YY Zhao","year":"2013","unstructured":"Zhao, Y. Y. et al. Intrarenal metabolomic investigation of chronic kidney disease and its TGF-beta1 mechanism in induced-adenine rats using UPLC Q-TOF\/HSMS\/MS(E). Journal of proteome research. \n                           12, 692\u2013703 (2013).","journal-title":"Journal of proteome research."},{"key":"3249_CR26","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1021\/acs.jproteome.6b00583","volume":"15","author":"Z-H Zhang","year":"2016","unstructured":"Zhang, Z.-H. et al. Metabolomic Signatures of Chronic Kidney Disease of Diverse Etiologies in the Rats and Humans. Journal of proteome research. \n                           15, 3802\u20133812 (2016).","journal-title":"Journal of proteome research."},{"key":"3249_CR27","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.cca.2011.12.014","volume":"413","author":"YY Zhao","year":"2012","unstructured":"Zhao, Y. Y. et al. Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF\/MS. Clin Chim Acta. \n                           413, 642\u2013649 (2012).","journal-title":"Clin Chim Acta."},{"key":"3249_CR28","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1039\/b604498k","volume":"131","author":"T Sangster","year":"2006","unstructured":"Sangster, T., Major, H., Plumb, R., Wilson, A. J. & Wilson, I. D. A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. The Analyst. \n                           131, 1075\u20131078 (2006).","journal-title":"The Analyst."},{"key":"3249_CR29","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jchromb.2009.01.007","volume":"877","author":"BM Warrack","year":"2009","unstructured":"Warrack, B. M. et al. Normalization strategies for metabonomic analysis of urine samples. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. \n                           877, 547\u2013552 (2009).","journal-title":"Journal of chromatography. B, Analytical technologies in the biomedical and life sciences."},{"key":"3249_CR30","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1021\/ac051495j","volume":"78","author":"S Bijlsma","year":"2006","unstructured":"Bijlsma, S. et al. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Analytical chemistry. \n                           78, 567\u2013574 (2006).","journal-title":"Analytical chemistry."},{"key":"3249_CR31","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3390\/toxins2112490","volume":"2","author":"RP Miller","year":"2010","unstructured":"Miller, R. P., Tadagavadi, R. K., Ramesh, G. & Reeves, W. B. Mechanisms of Cisplatin nephrotoxicity. Toxins. \n                           2, 2490\u20132518 (2010).","journal-title":"Toxins."},{"key":"3249_CR32","doi-asserted-by":"publisher","first-page":"W251","DOI":"10.1093\/nar\/gkv380","volume":"43","author":"J Xia","year":"2015","unstructured":"Xia, J., Sinelnikov, I. V., Han, B. & Wishart, D. S. MetaboAnalyst 3.0\u2013making metabolomics more meaningful. Nucleic acids research. \n                           43, W251\u2013257 (2015).","journal-title":"Nucleic acids research."},{"key":"3249_CR33","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1016\/j.procbio.2012.07.008","volume":"47l","author":"YY Zhao","year":"2012","unstructured":"Zhao, Y. Y. et al. Urinary metabonomics study on the protective effects of ergosta-4,6,8(14),22-tetraen-3-one on chronic renal failure in rats using UPLC Q-TOF-MS and a novel MSE data collection technique. Process Biochemistry. \n                           47l, 1980\u20131987 (2012).","journal-title":"Process Biochemistry."},{"key":"3249_CR34","doi-asserted-by":"publisher","first-page":"e115467","DOI":"10.1371\/journal.pone.0115467","volume":"9","author":"YY Zhao","year":"2014","unstructured":"Zhao, Y. Y. et al. A pharmaco-metabonomic study on chronic kidney disease and therapeutic effect of ergone by UPLC-QTOF\/HDMS. PLoS One \n                           9, e115467 (2014).","journal-title":"PLoS One"},{"key":"3249_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jchromb.2015.10.014","volume":"1026","author":"J Shi","year":"2016","unstructured":"Shi, J. et al. Metabolomics and its application to the evaluation of the efficacy and toxicity of traditional Chinese herb medicines. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. \n                           1026, 204\u2013216 (2016).","journal-title":"Journal of chromatography. B, Analytical technologies in the biomedical and life sciences."},{"key":"3249_CR36","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.cca.2012.06.005","volume":"413","author":"YY Zhao","year":"2012","unstructured":"Zhao, Y. Y. et al. Effect of ergosta-4,6,8(14),22-tetraen-3-one (ergone) on adenine-induced chronic renal failure rat: a serum metabonomic study based on ultra performance liquid chromatography\/high-sensitivity mass spectrometry coupled with MassLynx i-FIT algorithm. Clin Chim Acta. \n                           413, 1438\u20131445 (2012).","journal-title":"Clin Chim Acta."},{"key":"3249_CR37","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/jat.2933","volume":"34","author":"T Uehara","year":"2014","unstructured":"Uehara, T. et al. Identification of metabolomic biomarkers for drug-induced acute kidney injury in rats. Journal of applied toxicology: JAT. \n                           34, 1087\u20131095 (2014).","journal-title":"Journal of applied toxicology: JAT."},{"key":"3249_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1039\/C5MB00492F","volume":"12","author":"AJ Won","year":"2016","unstructured":"Won, A. J. et al. Discovery of urinary metabolomic biomarkers for early detection of acute kidney injury. Mol Biosyst. \n                           12, 133\u2013144 (2016).","journal-title":"Mol Biosyst."},{"key":"3249_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00726-009-0269-0","volume":"37","author":"G Wu","year":"2009","unstructured":"Wu, G. Amino acids: metabolism, functions, and nutrition. Amino acids. \n                           37, 1\u201317 (2009).","journal-title":"Amino acids."},{"key":"3249_CR40","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.redox.2017.03.017","volume":"12","author":"DQ Chen","year":"2017","unstructured":"Chen, D. Q. et al. Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt\/\u03b2-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease. Redox Biology. \n                           12, 505\u2013521 (2017).","journal-title":"Redox Biology."},{"key":"3249_CR41","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.clnu.2010.02.005","volume":"29","author":"G Garibotto","year":"2010","unstructured":"Garibotto, G. et al. Amino acid and protein metabolism in the human kidney and in patients with chronic kidney disease. Clin Nutr. \n                           29, 424\u2013433 (2010).","journal-title":"Clin Nutr."},{"key":"3249_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2215\/CJN.06000613","volume":"9","author":"F Duranton","year":"2014","unstructured":"Duranton, F. et al. Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function. Clin J Am Soc Nephrol. \n                           9, 37\u201345 (2014).","journal-title":"Clin J Am Soc Nephrol."},{"key":"3249_CR43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/ajcn\/24.2.243","volume":"24","author":"RR Brown","year":"1971","unstructured":"Brown, R. R. Biochemistry and pathology of tryptophan metabolism and its regulation by amino acids, vitamin B6, and steroid hormones. The American journal of clinical nutrition \n                           24, 243\u2013247 (1971).","journal-title":"The American journal of clinical nutrition"},{"key":"3249_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jep.2016.04.028","volume":"188","author":"L Feng","year":"2016","unstructured":"Feng, L. et al. Anti-stress effects of ginseng total saponins on hindlimb-unloaded rats assessed by a metabolomics study. Journal of ethnopharmacology \n                           188, 39\u201347 (2016).","journal-title":"Journal of ethnopharmacology"},{"key":"3249_CR45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.tox.2004.08.023","volume":"207","author":"RE Williams","year":"2005","unstructured":"Williams, R. E., Major, H., Lock, E. A., Lenz, E. M. & Wilson, I. D. D-Serine-induced nephrotoxicity: a HPLC-TOF\/MS-based metabonomics approach. Toxicology. \n                           207, 179\u2013190 (2005).","journal-title":"Toxicology."},{"key":"3249_CR46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrneph.2011.152","volume":"8","author":"RH Weiss","year":"2011","unstructured":"Weiss, R. H. & Kim, K. Metabolomics in the study of kidney diseases. Nature reviews. Nephrology \n                           8, 22\u201333 (2011).","journal-title":"Nature reviews. Nephrology"},{"key":"3249_CR47","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/ki.2010.440","volume":"79","author":"HN Kwon","year":"2011","unstructured":"Kwon, H. N. et al. Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach. Kidney international. \n                           79, 529\u2013537 (2011).","journal-title":"Kidney international."},{"key":"3249_CR48","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.yexcr.2011.11.008","volume":"318","author":"F Rovetta","year":"2012","unstructured":"Rovetta, F. et al. ER signaling regulation drives the switch between autophagy and apoptosis in NRK-52E cells exposed to cisplatin. Exp Cell Res. \n                           318, 238\u2013250 (2012).","journal-title":"Exp Cell Res."},{"key":"3249_CR49","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s10157-009-0254-7","volume":"14","author":"K Inoue","year":"2010","unstructured":"Inoue, K. et al. Cisplatin-induced macroautophagy occurs prior to apoptosis in proximal tubules in vivo. Clinical and experimental nephrology. \n                           14, 112\u2013122 (2010).","journal-title":"Clinical and experimental nephrology."},{"key":"3249_CR50","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.6b00956","author":"H Chen","year":"2017","unstructured":"Chen, H. et al. Combined clinical phenotype and lipidomic analysis reveals the impact of chronic kidney disease on lipid metabolism. J Proteome Res. doi:10.1021\/acs.jproteome.6b00956 (2017).","journal-title":"J Proteome Res"},{"key":"3249_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw415","author":"DQ Chen","year":"2017","unstructured":"Chen, D. Q. et al. The link between phenotype and fatty acid metabolism in advanced chronic kidney disease. Nephrology Dialysis Transplantation. doi:10.1093\/ndt\/gfw415 (2017).","journal-title":"Nephrology Dialysis Transplantation."},{"key":"3249_CR52","doi-asserted-by":"publisher","first-page":"41954","DOI":"10.1038\/srep41954","volume":"7","author":"H Liu","year":"2017","unstructured":"Liu, H. et al. Mass spectrometry imaging of kidney tissue sections of rat subjected to unilateral ureteral obstruction. Sci Rep. \n                           7, 41954 (2017).","journal-title":"Sci Rep."},{"key":"3249_CR53","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1007\/s00216-016-9368-4","volume":"408","author":"Z Xiang","year":"2016","unstructured":"Xiang, Z., Sun, H., Cai, X. & Chen, D. The study on serum and urine of renal interstitial fibrosis rats induced by unilateral ureteral obstruction based on metabonomics and network analysis methods. Anal Bioanal Chem. \n                           408, 2607\u20132619 (2016).","journal-title":"Anal Bioanal Chem."},{"key":"3249_CR54","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jep.2015.03.025","volume":"166","author":"SY Gao","year":"2015","unstructured":"Gao, S. Y. et al. Urinary metabonomics elucidate the therapeutic mechanism of Orthosiphon stamineus in mouse crystal-induced kidney injury. Journal of Ethnopharmacology. \n                           166, 323\u2013332 (2015).","journal-title":"Journal of Ethnopharmacology."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03249-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03249-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03249-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T05:30:40Z","timestamp":1671773440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03249-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,15]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["3249"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-03249-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,15]]},"assertion":[{"value":"16 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3619"}}